Comparable stake leader
Louis C. Lucido
SEC ownership of BioCorRx Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001443863.
Disclosed value leader
Louis C. Lucido
Comparable rows
0/7
Latest evidence
28 Jun 2024
- Public ticker
- BICX on OTC
- Parsed ownership sources
-
3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Louis C. Lucido
Ranking: Comparable ownership first, then disclosed value
- Latest parsed ownership date
-
28 Jun 2024
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001443863
- Issuer location
- Anaheim, CA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of BioCorRx Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Louis C. Lucido
Disclosed value leader
Louis C. Lucido
Comparable rows
0/7
Latest evidence
28 Jun 2024
3/4/5
Highest disclosed value: $405,017
7 rows are not safely comparable across share classes.
Quick read
Louis C. Lucido has the largest disclosed position value at $405K.
0 of 7 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Louis C. Lucido's linked filing trail.
Disclosed position value
Top 5
Louis C. Lucido
$405K
Joseph J. Galligan
$166.5K
Kent Emry
$79.8K
Lourdes Felix
$56.3K
Luisa Ingargiola
$33.9K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-7 of 7 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Louis C. Lucido |
3/4/5
President, Director, 10%+ Owner
|
—
class O/S missing
|
$405,017
2,511,940 shares
|
— | 28 Jun 2024 |
| Joseph J. Galligan |
3/4/5
Director, 10%+ Owner
|
—
class O/S missing
|
$166,501
237,858 shares
|
— | 02 Jan 2024 |
| Kent Emry |
3/4/5
Director
|
—
class O/S missing
|
$79,846
114,065 shares
|
— | 29 Sep 2023 |
| Lourdes Felix |
3/4/5
CEO and CFO, Director
|
—
class O/S missing
|
$56,277
843,578 shares
|
— | 28 Jun 2024 |
| Luisa Ingargiola |
3/4/5
Director
|
—
class O/S missing
|
$33,895
64,191 shares
|
— | 28 Mar 2024 |
| Harsha Murthy |
3/4/5
Director
|
—
class O/S missing
|
$13,803
19,719 shares
|
— | 02 Jan 2024 |
| Brady James Granier |
3/4/5
Director
|
—
class O/S missing
|
—
16,698 shares
|
— | 28 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 22 Aug 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-7 of 7 reporting-owner rows connected to BioCorRx Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
7
Largest Forms 3/4/5 holder
Louis C. Lucido
Net 12M change
$0
Latest report
28 Jun 2024
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Louis C. Lucido | President, Director, 10%+ Owner | $405,017 | Mixed | 28 Jun 2024 | ||
| Joseph J. Galligan | Director, 10%+ Owner | $166,501 | Mixed | 02 Jan 2024 | ||
| Kent Emry | Director | $79,846 | Mixed | 29 Sep 2023 | ||
| Lourdes Felix | CEO and CFO, Director | $56,277 | Mixed | 28 Jun 2024 | ||
| Luisa Ingargiola | Director | $33,895 | Mixed | 28 Mar 2024 | ||
| Harsha Murthy | Director | $13,803 | Mixed | 02 Jan 2024 | ||
| Brady James Granier | Director | Mixed | 28 Mar 2024 |
Recent insider transactions for BioCorRx Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.